Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jan 18:2012:0805.

Menorrhagia

Kirsten Duckitt  1 , Sally Collins
Affiliations

Menorrhagia

Kirsten Duckitt et al. BMJ Clin Evid. .

Abstract

Introduction: Menorrhagia limits normal activities, and causes anaemia in two-thirds of women with objective menorrhagia (loss of 80 mL blood per cycle). Prostaglandin disorders may be associated with idiopathic menorrhagia, and with heavy bleeding due to fibroids, adenomyosis, or use of intrauterine devices (IUDs). Fibroids have been found in 10% of women with menorrhagia overall, and in 40% of women with severe menorrhagia; but half of women having a hysterectomy for menorrhagia are found to have a normal uterus.

Methods and outcomes: We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of medical treatments for menorrhagia? What are the effects of surgical treatments for menorrhagia? What are the effects of endometrial thinning before endometrial destruction in treating menorrhagia? We searched: Medline, Embase, The Cochrane Library, and other important databases up to June 2011 (Clinical Evidence reviews are updated periodically; please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations, such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).

Results: We found 39 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.

Conclusions: In this systematic review we present information relating to the effectiveness and safety of the following medical interventions: combined pill, danazol, etamsylate, gonadorelin analogues, intrauterine progesterone, non-steroidal anti-inflammatory drugs (NSAIDs), progestogens, and the following surgical interventions: dilatation and curettage, endometrial destruction, and hysterectomy.

PubMed Disclaimer

References

    1. Hallberg L, Hogdahl A, Nilsson L, et al. Menstrual blood loss – a population study: variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand 1966;45:320–351. - PubMed
    1. Vessey MP, Villard-Mackintosh L, McPherson K, et al. The epidemiology of hysterectomy: findings in a large cohort study. Br J Obstet Gynaecol 1992;99:402–407. - PubMed
    1. Working Party of the National Health Committee New Zealand. Guidelines for the management of heavy menstrual bleeding. Wellington: Ministry of Health, 1998 (available from The Ministry of Health, 133 Molesworth Street, PO Box 5013, Wellington, New Zealand). Search date 1996.
    1. Smith SK, Abel MH, Kelly RW, et al. A role for prostacyclin (PGI2) in excessive menstrual bleeding. Lancet 1981;1:522–524. - PubMed
    1. Rybo G, Leman J, Tibblin R. Epidemiology of menstrual blood loss. In: Baird DT, Michie EA, eds. Mechanisms of menstrual bleeding. New York: Raven Press, 1985:181–193.

Publication types

LinkOut - more resources